ENDRA Life Sciences Inc. SEC filings NDRA
ENDRA Life Sciences Inc. has 544 filings in SEC EDGAR's recent list, going back to Aug 9, 2016. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Form 425 | Oct 26, 2026 | — |
| 425 | Current report | Oct 1, 2026 | — |
| 425 | Form 425 | Sep 25, 2026 | — |
| 425 | Form 425 | Sep 14, 2026 | — |
| 425 | Filing | Sep 9, 2026 | — |
| 425 | Form 425 | Sep 9, 2026 | — |
| 425 | Form 425 | Aug 21, 2026 | — |
| 425 | Filing | Aug 20, 2026 | — |
| 425 | Current report | Aug 17, 2026 | — |
| 425 | Filing | Aug 6, 2026 | — |
| 425 | Filing | Aug 5, 2026 | — |
| 425 | Filing | Aug 4, 2026 | — |
| 425 | Filing | Jul 22, 2026 | — |
| 425 | Filing | Jul 22, 2026 | — |
| 425 | Form 425 | Jul 17, 2026 | — |
| 425 | Form 425 | Jul 17, 2026 | — |
| 425 | Current report | Jun 26, 2026 | — |
| 425 | Filing | Jun 25, 2026 | — |
| 425 | Current report | Jun 25, 2026 | — |
| RW | Withdrawal request | May 26, 2026 | — |
| D | Filing | Oct 24, 2025 | — |
| DRS | Filing | May 9, 2025 | — |
| NT 10-Q | Form nt 10-q | Nov 15, 2024 | Sep 30, 2024 |
| EFFECT | Filing | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2024 | — |
| EFFECT | Filing | Apr 3, 2024 | — |
| CORRESP | Letter to the SEC | Apr 1, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2024 | — |
| EFFECT | Filing | Apr 27, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| 8-A12G | Form 8-a12g | Sep 27, 2022 | — |
| 25-NSE | Delisting notice | May 12, 2022 | — |
| EFFECT | Filing | May 3, 2021 | — |
| CORRESP | Letter to the SEC | Apr 29, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2021 | — |
| EFFECT | Filing | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 22, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2020 | — |
| D | Filing | Dec 20, 2019 | — |
| EFFECT | Filing | Sep 13, 2019 | — |
| CORRESP | Letter to the SEC | Sep 11, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2019 | — |
| D | Filing | Jul 31, 2019 | — |
| EFFECT | Filing | Feb 12, 2019 | — |
| EFFECT | Filing | Feb 8, 2019 | — |
| EFFECT | Filing | Sep 4, 2018 | — |
| EFFECT | Filing | Sep 4, 2018 | — |
| CORRESP | Letter to the SEC | Aug 30, 2018 | — |
| CORRESP | Letter to the SEC | Aug 30, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2018 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2018 | — |
| D | Filing | Jul 3, 2018 | — |
| 25-NSE | Delisting notice | Jun 27, 2017 | — |
| EFFECT | Filing | May 8, 2017 | — |
| CERTNAS | Auto-generated paper document | May 4, 2017 | — |
| CERTNYS | Auto-generated paper document | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| CORRESP | Letter to the SEC | May 4, 2017 | — |
| 8-A12B/A | Form 8-a12b/a | May 4, 2017 | — |
| CERTNAS | Auto-generated paper document | Apr 18, 2017 | — |
| CORRESP | Letter to the SEC | Apr 18, 2017 | — |
| CORRESP | Letter to the SEC | Apr 18, 2017 | — |
| 8-A12B/A | Filing | Apr 18, 2017 | — |
| CORRESP | Letter to the SEC | Apr 14, 2017 | — |
| CORRESP | Letter to the SEC | Jan 31, 2017 | — |
| CORRESP | Letter to the SEC | Jan 31, 2017 | — |
| CORRESP | Letter to the SEC | Jan 26, 2017 | — |
| 8-A12B/A | Filing | Jan 24, 2017 | — |
| CORRESP | Letter to the SEC | Jan 24, 2017 | — |
| CORRESP | Letter to the SEC | Jan 24, 2017 | — |
| 8-A12B/A | Filing | Dec 19, 2016 | — |
| 8-A12B | Filing | Dec 16, 2016 | — |
| CORRESP | Letter to the SEC | Dec 15, 2016 | — |
| CORRESP | Letter to the SEC | Dec 15, 2016 | — |
| CORRESP | Letter to the SEC | Dec 15, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2016 | — |
| CORRESP | Letter to the SEC | Dec 6, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2016 | — |
| CORRESP | Letter to the SEC | Nov 18, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2016 | — |
| DRSLTR | Filing | Sep 21, 2016 | — |
| DRS/A | Filing | Sep 21, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2016 | — |
| DRS | Filing | Aug 9, 2016 | — |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NDRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ann Arbor, MI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1681682
- Former names
- Endra Inc. (until Sep 21, 2016)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.